X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (140743) 140743
Book Review (22973) 22973
Newsletter (22102) 22102
Newspaper Article (19324) 19324
Publication (8180) 8180
Web Resource (1327) 1327
Trade Publication Article (1248) 1248
Book Chapter (773) 773
Conference Proceeding (746) 746
Magazine Article (744) 744
Book / eBook (219) 219
Transcript (206) 206
Dissertation (109) 109
Report (44) 44
Reference (17) 17
Government Document (15) 15
Paper (15) 15
Journal / eJournal (8) 8
Streaming Video (7) 7
Data Set (6) 6
Presentation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (107136) 107136
humans (105506) 105506
lymphomas (66073) 66073
male (56533) 56533
female (54409) 54409
oncology (44919) 44919
cancer (41567) 41567
middle aged (38279) 38279
adult (36830) 36830
hematology (31342) 31342
aged (28776) 28776
chemotherapy (26142) 26142
lymphoma (25287) 25287
research (22317) 22317
care and treatment (22034) 22034
adolescent (19274) 19274
leukemia (18066) 18066
child (17157) 17157
antineoplastic combined chemotherapy protocols - therapeutic use (16881) 16881
prognosis (16534) 16534
non-hodgkin's lymphomas (16089) 16089
animals (14770) 14770
treatment outcome (14615) 14615
non-hodgkins-lymphoma (11894) 11894
abridged index medicus (11791) 11791
therapy (11632) 11632
child, preschool (10771) 10771
tumors (10489) 10489
medical research (10064) 10064
health aspects (9752) 9752
drug therapy (9690) 9690
aged, 80 and over (9638) 9638
transplantation (9633) 9633
retrospective studies (9629) 9629
antineoplastic agents - therapeutic use (9324) 9324
cancer therapies (9286) 9286
apoptosis (9274) 9274
analysis (9191) 9191
patients (9187) 9187
rituximab (8954) 8954
t cells (8785) 8785
mice (8704) 8704
risk factors (8429) 8429
diagnosis (8361) 8361
clinical trials (8342) 8342
reports (8096) 8096
disease (8032) 8032
precursor cell lymphoblastic leukemia-lymphoma - drug therapy (7976) 7976
antineoplastic agents (7847) 7847
immunology (7833) 7833
combined modality therapy (7730) 7730
b-cell lymphoma (7428) 7428
antimitotic agents (7411) 7411
genetic aspects (7400) 7400
immunotherapy (7277) 7277
lymphoma, non-hodgkin - drug therapy (7200) 7200
expression (7040) 7040
pediatrics (6992) 6992
medicine & public health (6908) 6908
radiotherapy (6715) 6715
young adult (6505) 6505
pathology (6469) 6469
lymphoma - drug therapy (6467) 6467
stem cells (6458) 6458
follow-up studies (6449) 6449
pharmaceutical industry (6351) 6351
survival (6333) 6333
children (6300) 6300
remission induction (6070) 6070
medicine, experimental (6012) 6012
infant (5985) 5985
neoplasm staging (5956) 5956
oncology, experimental (5804) 5804
cell line, tumor (5685) 5685
diagnosis, differential (5546) 5546
disease-free survival (5544) 5544
hemic and lymphatic diseases (5468) 5468
proteins (5457) 5457
lymphoma - therapy (5443) 5443
recurrence (5431) 5431
cyclophosphamide - administration & dosage (5427) 5427
survival rate (5361) 5361
lymphocytes (5351) 5351
biopsy (5214) 5214
immunohistochemistry (5105) 5105
time factors (5101) 5101
vincristine - administration & dosage (5055) 5055
lymphoma - pathology (5053) 5053
survival analysis (5051) 5051
universities and colleges (4999) 4999
gene expression (4941) 4941
acute lymphoblastic-leukemia (4844) 4844
medicine, general & internal (4835) 4835
lymphoma, non-hodgkin - therapy (4780) 4780
medicine (4668) 4668
surgery (4653) 4653
precursor cell lymphoblastic leukemia-lymphoma - therapy (4557) 4557
lymphoma, non-hodgkin - pathology (4528) 4528
studies (4501) 4501
mutation (4469) 4469
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (116) 116
Online Resources - Online (38) 38
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (17) 17
Collection Dvlpm't (Acquisitions) - Vendor file (12) 12
Collection Dvlpm't (Acquisitions) - Closed Orders (6) 6
Scarborough Hospital - Online (4) 4
Scarborough Hospital - Hospital Department (3) 3
Scarborough Hospital - General (2) 2
Credit Valley Hospital - Stacks (1) 1
Gerstein Science - Circulation Desk (1) 1
Markham Stouffville Hospital - Stacks (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Reference (1) 1
Thomas Fisher Rare Book - Rare Book (1) 1
UTL at Downsview - May be requested (1) 1
UofT Schools - Stacks (1) 1
UofT at Mississauga - Stacks (1) 1
UofT at Scarborough - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (173441) 173441
Japanese (2646) 2646
German (2524) 2524
French (2285) 2285
Chinese (1220) 1220
Spanish (1156) 1156
Russian (1077) 1077
Polish (602) 602
Italian (510) 510
Korean (220) 220
Czech (150) 150
Hungarian (142) 142
Portuguese (136) 136
Dutch (114) 114
Danish (87) 87
Turkish (67) 67
Croatian (60) 60
Norwegian (56) 56
Serbian (46) 46
Finnish (41) 41
Hebrew (40) 40
Romanian (40) 40
Swedish (28) 28
Slovak (16) 16
Bulgarian (14) 14
Ukrainian (13) 13
Persian (6) 6
Slovenian (6) 6
Lithuanian (5) 5
Bosnian (4) 4
Greek (3) 3
Latvian (2) 2
Afrikaans (1) 1
Catalan (1) 1
Galician (1) 1
Manx (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cancer Chemotherapy and Pharmacology, ISSN 0344-5704, 8/2016, Volume 78, Issue 2, pp. 305 - 312
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2015, Volume 92, Issue 1, pp. 11 - 31
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2001, Volume 19, Issue 3, pp. 742 - 749
Purpose: To assess the feasibility and efficacy of intensive chemotherapy with hematopoietic stem-cell rescue (IC + HCR) in patients with refractory or... 
THERAPY | BONE-MARROW TRANSPLANTATION | ONCOLOGY | MODALITY | METHOTREXATE | PROTOCOL | MALIGNANCIES | HIGH-DOSE CHEMOTHERAPY | RADIOTHERAPY | RADIATION | NERVOUS-SYSTEM LYMPHOMA | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Thiotepa - administration & dosage | Humans | Lymphoma, B-Cell - therapy | Middle Aged | Salvage Therapy | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Neoplasm Recurrence, Local - drug therapy | Male | Eye Neoplasms - therapy | Lymphoma, Large-Cell, Immunoblastic - therapy | Busulfan - administration & dosage | Feasibility Studies | Dose-Response Relationship, Drug | Eye Neoplasms - drug therapy | Lymphoma, Large B-Cell, Diffuse - therapy | Hematopoietic Stem Cell Transplantation - adverse effects | Adult | Female | Lymphoma, B-Cell - drug therapy | Lymphoma, Non-Hodgkin - drug therapy | Lymphoma, Large B-Cell, Diffuse - drug therapy | Neoplasm Recurrence, Local - therapy | Central Nervous System Neoplasms - therapy | Etoposide - administration & dosage | Combined Modality Therapy | Cytarabine - administration & dosage | Disease-Free Survival | Lymphoma, T-Cell - drug therapy | Lymphoma, Non-Hodgkin - therapy | Lymphoma, T-Cell - therapy | Lymphoma, Large-Cell, Immunoblastic - drug therapy | Methotrexate - administration & dosage | Nervous System Diseases - chemically induced | Central Nervous System Neoplasms - drug therapy | Index Medicus
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 11/2008, Volume 26, Issue 32, pp. 5156 - 5164
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2014, Volume 89, Issue 1, pp. 49 - 58
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 12/2012, Volume 30, Issue 36, pp. 4462 - 4469
Journal Article
International Journal of Hyperthermia, ISSN 0265-6736, 08/2016, Volume 32, Issue 6, pp. 595 - 599
Background: Isolated limb perfusion (ILP) is an established and effective treatment for advanced melanoma and soft tissue sarcomas of the extremities with a... 
isolated limb perfusion | Advanced status | local control | rare tumours | SOFT-TISSUE SARCOMAS | COMPLETE REMISSION | EXTREMITIES | NECROSIS-FACTOR-ALPHA | T-CELL LYMPHOMA | MALIGNANT-MELANOMA | REGIONAL PERFUSION | ONCOLOGY | TNF-ALPHA | MELPHALAN | CARCINOMA | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Humans | Lymphoma, B-Cell - therapy | Rare Diseases - drug therapy | Carcinoma, Merkel Cell - therapy | Giant Cell Tumors - therapy | Melphalan - therapeutic use | Synovitis, Pigmented Villonodular - therapy | Carcinoma, Merkel Cell - drug therapy | Synovitis, Pigmented Villonodular - drug therapy | Fibromatosis, Aggressive - therapy | Hyperthermia, Induced | Adenomatous Polyposis Coli - therapy | Extremities | Fibromatosis, Aggressive - drug therapy | Lymphoma, B-Cell - drug therapy | Abdominal Neoplasms - therapy | Abdominal Neoplasms - drug therapy | Carcinoma, Squamous Cell - therapy | Antineoplastic Agents, Alkylating - therapeutic use | Tumor Necrosis Factor-alpha - therapeutic use | Carcinoma, Squamous Cell - drug therapy | Giant Cell Tumors - drug therapy | Rare Diseases - therapy | Perfusion | Adenomatous Polyposis Coli - drug therapy | Chemotherapy, Cancer, Regional Perfusion | Index Medicus | necrosis-factor-alpha | melphalan | Oncology | t-cell lymphoma | Nuclear Medicine & Medical Imaging | Klinisk medicin | tnf-alpha | extremities | Clinical Medicine | carcinoma | complete remission | Radiology | soft-tissue sarcomas | malignant-melanoma | regional perfusion
Journal Article
Nature, ISSN 0028-0836, 02/2015, Volume 518, Issue 7537, pp. 107 - 110
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2013, Volume 87, Issue 5, pp. 1086 - 1093
Purpose To assess the dosimetric benefit, treatment outcome, and toxicity of high-dose and extended-field intensity modulated radiation therapy (IMRT) in... 
Radiology | Hematology, Oncology and Palliative Medicine | HEAD | NASOPHARYNGEAL CARCINOMA | PROGNOSTIC-FACTORS | ONCOLOGY | NASAL-TYPE | ARC THERAPY | TOXICITY | EXPERIENCE | RADIOTHERAPY | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | NECK CANCER | CHEMOTHERAPY | Organs at Risk - radiation effects | Pharyngeal Neoplasms - radiotherapy | Humans | Middle Aged | Male | Oropharyngeal Neoplasms - pathology | Pharyngeal Neoplasms - drug therapy | Nasopharyngeal Neoplasms - pathology | Young Adult | Child | Radiotherapy Planning, Computer-Assisted | Lymphatic Irradiation - methods | Radiotherapy, Intensity-Modulated - mortality | Radiotherapy Dosage | Nasopharyngeal Neoplasms - diagnostic imaging | Nose Neoplasms - pathology | Oropharyngeal Neoplasms - drug therapy | Radiotherapy, Intensity-Modulated - methods | Oropharyngeal Neoplasms - radiotherapy | Pharyngeal Neoplasms - diagnostic imaging | Pharyngeal Neoplasms - mortality | Radiography | Lymphoma, Extranodal NK-T-Cell - pathology | Parotid Gland - radiation effects | Adolescent | Organs at Risk - diagnostic imaging | Lymphoma, Extranodal NK-T-Cell - mortality | Pharyngeal Neoplasms - pathology | Xerostomia - etiology | Nasopharyngeal Neoplasms - mortality | Oropharyngeal Neoplasms - diagnostic imaging | Oropharyngeal Neoplasms - mortality | Radiotherapy, Intensity-Modulated - adverse effects | Organ Sparing Treatments - methods | Nasopharyngeal Neoplasms - radiotherapy | Lymphoma, Extranodal NK-T-Cell - drug therapy | Lymphoma, Extranodal NK-T-Cell - radiotherapy | Nose Neoplasms - radiotherapy | Adult | Female | Lymphatic Irradiation - adverse effects | Retrospective Studies | Nasopharyngeal Neoplasms - drug therapy | Neck | Parotid Gland - diagnostic imaging | Neoplasm Invasiveness | Treatment Outcome | Xerostomia - prevention & control | Disease-Free Survival | Lymphoma, Extranodal NK-T-Cell - diagnostic imaging | Care and treatment | Lymphomas | Radiotherapy | Nuclear radiation | Patient outcomes | Index Medicus | LYMPHOMAS | GLANDS | LYMPH NODES | RADIOLOGY AND NUCLEAR MEDICINE | RADIATION DOSES | GY RANGE 10-100 | PLANNING
Journal Article
1991, Hematology, ISBN 9780824784553, Volume 14., x, 438
Book